These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study. Newman-Tancredi A, Cussac D, Audinot V, Pasteau V, Gavaudan S, Millan MJ. Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542 [Abstract] [Full Text] [Related]
9. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release. Cosi C, Carilla-Durand E, Assié MB, Ormiere AM, Maraval M, Leduc N, Newman-Tancredi A. Eur J Pharmacol; 2006 Mar 27; 535(1-3):135-44. PubMed ID: 16554049 [Abstract] [Full Text] [Related]
15. Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors. Tadori Y, Forbes RA, McQuade RD, Kikuchi T. Eur J Pharmacol; 2008 Nov 12; 597(1-3):27-33. PubMed ID: 18831971 [Abstract] [Full Text] [Related]
16. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors. Hidaka K, Tada S, Matsumoto M, Ohmori J, Tasaki Y, Nomura T, Usuda S, Yamaguchi T. Br J Pharmacol; 1996 Apr 12; 117(8):1625-32. PubMed ID: 8732269 [Abstract] [Full Text] [Related]
18. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain. Sóvágó J, Makkai B, Gulyás B, Hall H. Eur J Neurosci; 2005 Jul 12; 22(1):65-71. PubMed ID: 16029196 [Abstract] [Full Text] [Related]
19. Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile. Kiss B, Horváth A, Némethy Z, Schmidt E, Laszlovszky I, Bugovics G, Fazekas K, Hornok K, Orosz S, Gyertyán I, Agai-Csongor E, Domány G, Tihanyi K, Adham N, Szombathelyi Z. J Pharmacol Exp Ther; 2010 Apr 12; 333(1):328-40. PubMed ID: 20093397 [Abstract] [Full Text] [Related]
20. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors. Millan MJ, Mannoury la Cour C, Novi F, Maggio R, Audinot V, Newman-Tancredi A, Cussac D, Pasteau V, Boutin JA, Dubuffet T, Lavielle G. J Pharmacol Exp Ther; 2008 Feb 12; 324(2):587-99. PubMed ID: 18024789 [Abstract] [Full Text] [Related] Page: [Next] [New Search]